230
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients

, , , , , , , , , , , , & show all
Pages 498-504 | Accepted 19 Feb 2013, Published online: 11 May 2013

References

  • Felson DT. Epidemiology of hip and knee osteoarthritis. Epidemiol Rev 1988;10:1–28.
  • Bian Q, Wang YJ, Liu SF, Li YP. Osteoarthritis: genetic factors, animal models, mechanisms, and therapies. Front Biosci (Elite Ed) 2012;4:74–100.
  • Botter SM, van Osch GJ, Waarsing JH, van der Linden JC, Verhaar JA, Pols HA, Cartilage damage pattern in relation to subchondral plate thickness in a collagenase-induced model of osteoarthritis. Osteoarthritis Cartilage 2008;16:506–14.
  • Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010;6:625–35.
  • Zhang F, Guo X, Duan C, Wu S, Yu H, Lammi M. Identification of differentially expressed genes and pathways between primary osteoarthritis and endemic osteoarthritis (Kashin-Beck disease). Scand J Rheumatol 2013;42:71–9.
  • Kapadia RD, Badger AM, Levin JM, Swift B, Bhattacharyya A, Dodds RA, Meniscal ossification in spontaneous osteoarthritis in the guinea-pig. Osteoarthritis Cartilage 2000;8:374–7.
  • Young MF. Mouse models of osteoarthritis provide new research tools. Trends Pharmacol Sci 2005;26:333–5.
  • Kato T, Xiang Y, Nakamura H, Nishioka K. Neoantigens in osteoarthritic cartilage. Curr Opin Rheumatol 2004;16:604–8.
  • Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Initial sequencing and analysis of the human genome. Nature 2001;409:860–921.
  • O’Connell C, O’Brien S, Nash WG, Cohen M. ERV3, a full-length human endogenous provirus: chromosomal localization and evolutionary relationships. Virology 1984;138:225–35.
  • Yi JM, Kim HM, Kim HS. Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells. J Gen Virol 2004;85:1203–10.
  • Lapatschek M, Durr S, Lower R, Magin C, Wagner H, Miethke T. Functional analysis of the env open reading frame in human endogenous retrovirus IDDMK(1,2)22 encoding superantigen activity. J Virol 2000;74:6386–93.
  • Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 2001;50:434–42.
  • Reynier F, Verjat T, Turrel F, Imbert PE, Marotte H, Mougin B, Increase in human endogenous retrovirus HERV-K (HML-2) viral load in active rheumatoid arthritis. Scand J Immunol 2009;70:295–9.
  • Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001;15:579–89.
  • Sicat J, Sutkowski N, Huber BT. Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J Rheumatol 2005;32:1821–31.
  • Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833–40.
  • Lequesne MG, Mery C, Samson M, Gerard P. Indexes of severity for osteoarthritis of the hip and knee. Validation - value in comparison with other assessment tests. Scand J Rheumatol Suppl 1987;65:85–9.
  • Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137–45.
  • Tai AK, O’Reilly EJ, Alroy KA, Simon KC, Munger KL, Huber BT, . Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis. Mult Scler 2008;14:1175–80.
  • Hsiao FC, Lin M, Tai A, Chen G, Huber BT. Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J Immunol 2006;177:2056–60.
  • Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008;3:1101–8.
  • Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26–35.
  • Hasuike S, Miura K, Miyoshi O, Miyamoto T, Niikawa N, Jinno Y, Isolation and localization of an IDDMK1,2-22-related human endogenous retroviral gene, and identification of a CA repeat marker at its locus. J Hum Genet 1999;44:343–7.
  • Turcanova VL, Bundgaard B, Hollsberg P. Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen. J Clin Virol 2009;46:15–19.
  • Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990;248:1066.
  • Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997;90:303–13.
  • Stauffer Y, Marguerat S, Meylan F, Ucla C, Sutkowski N, Huber B, Interferon-alpha-induced endogenous superantigen: a model linking environment and autoimmunity. Immunity 2001;15: 591–601.
  • Tai AK, Luka J, Ablashi D, Huber BT. HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol 2009;46:47–8.
  • Hsiao FC, Tai AK, Deglon A, Sutkowski N, Longnecker R, Huber BT. EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology 2009;385:261–6.
  • Rollín R, Alvarez-Lafuente R, Marco F, Lopez-Durán L, Hoyas JA, Jover JA, . The ubiquitin-proteasome pathway and viral infections in articular cartilage of patients with osteoarthritis. Rheumatol Int 2009;29:969–72.
  • Ding C, Jones G, Wluka AE, Cicuttini F. What can we learn about osteoarthritis by studying a healthy person against a person with early onset of disease? Curr Opin Rheumatol 2010; 22:520–7.
  • Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 2001;50:434–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.